Bi Yonghua, Yi Mengfei, Han Xinwei, Ren Jianzhuang
Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
J Int Med Res. 2020 Aug;48(8):300060520945506. doi: 10.1177/0300060520945506.
Thoracic endovascular aortic repair (TEVAR) is considered the mini-invasive treatment of choice for patients with Stanford type B aortic dissection (TBAD). This study aimed to investigate the clinical outcomes and quality of life (QoL) in patients with acute and subacute TBAD after TEVAR.
From January 2014 until July 2016, 22 acute patients (Group A) and 18 subacute patients received TEVAR (Group B), and 13 patients were managed non-operatively (Group C). The Medical Outcomes Study Short Form-36 was used to assess QoL preoperatively and after TEVAR. Operative techniques and complications were retrospectively analyzed.
The role emotion, vitality, and mental health domains scored well preoperatively. Except for role emotion, vitality, and mental health, the remaining domains significantly improved after TEVAR. There was no significant difference in QoL metrics between Groups A and B. In Group C, bodily pain and social functioning domains were improved, and role emotion was decreased, with no improvement in the remaining domains. The 3-year survival rates were 95.5%, 100%, and 85.7% for Groups A, B, and C, respectively.
TEVAR may be safe and effective in patients with acute and subacute TBAD with similar and favorable clinical and QoL metrics.
胸主动脉腔内修复术（TEVAR）被认为是斯坦福B型主动脉夹层（TBAD）患者的微创治疗选择。本研究旨在调查急性和亚急性TBAD患者接受TEVAR后的临床结局和生活质量（QoL）。
2014年1月至2016年7月，22例急性患者（A组）和18例亚急性患者接受了TEVAR（B组），13例患者接受非手术治疗（C组）。采用医学结局研究简表36评估术前及TEVAR术后的生活质量。对手术技术和并发症进行回顾性分析。
角色情感、活力和心理健康领域术前得分良好。除角色情感、活力和心理健康外，TEVAR术后其余领域均有显著改善。A组和B组在生活质量指标上无显著差异。C组中，身体疼痛和社会功能领域有所改善，角色情感下降，其余领域无改善。A、B、C组的3年生存率分别为95.5%、100%和85.7%。
TEVAR对于急性和亚急性TBAD患者可能是安全有效的，临床和生活质量指标相似且良好。
